Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phas... by Waddell, Tom, MBBCh, Chau, Ian, MD, Cunningham, David, Prof, Gonzalez, David, PhD, Okines, Alicia Frances Clare, MBBCh, Wotherspoon, Andrew, MBBCh, Saffery, Claire, Middleton, Gary, MD, Wadsley, Jonathan, MBBCh, Ferry, David, Prof, Mansoor, Wasat, PhD, Crosby, Tom, MBBS, Coxon, Fareeda, MBBS, Smith, David, MD, Waters, Justin, PhD, Iveson, Timothy, MD, Falk, Stephen, MD, Slater, Sarah, MD, Peckitt, Clare, MSc, Barbachano, Yolanda, PhD

Get full text